Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin

Author： Kim KwangYoun   Kim SangHun   Yu SunNyoung   Park SuelKi   Choi HyeunDeok   Yu HakSun   Ji JaeHoon   Seo YoungKyo   Ahn SoonCheol  

Publisher： Spandidos Publications

E-ISSN： 1791-3004|12|2|1898-1904

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.2, 2015-08, pp. : 1898-1904

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loperamide, an FDA-Approved Antidiarrhea Drug, Effectively Reverses the Resistance of Multidrug Resistant MCF-7/MDR1 Human Breast Cancer Cells to Doxorubicin-Induced Cytotoxicity

By Zhou Yanfei   Sridhar Rajagopalan   Shan Liang   Sha Wei   Gu Xinbin   Sukumar Saraswati  

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

JNK/SAPK Mediates Doxorubicin-Induced Differentiation and Apoptosis in MCF-7 Breast Cancer Cells

By Kim J.   Freeman M.R.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 321-328

Springer Publishing Company

Access to resources Recommend Favorite

Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity

By          

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 219-226

Spandidos Publications

Access to resources Recommend Favorite

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang   Wu Xiao-Nan   Chen Jie   Wang Wen-Xiang   Lu ZuFu  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite